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Consensus about the toxicity of silver nanoparticles (Ag-NPs) has not been reached, even though extensive attention has been
paid to this issue. This confusion may be due to physicochemical factors of Ag-NPs and the cell model used for biological safety
evaluation. In the present study, human embryonic stem cell-derived fibroblasts (EBFs), which have been considered a closer
representative of the in vivo response, were used as a novel cell model to assess the cytotoxicity of Ag-NPs (∼20 nm and ∼100 nm)
in comparison with L-929 fibroblast cell line. Cell proliferation, cell cycle, apoptosis, p53 expression, and cellular uptake were
examined. Results showed that Ag-NPs presented higher cytotoxicity to EBF than to L-929. EBF demonstrated a stronger capacity
to ingest Ag-NPs, a higher G2/M arrest, and more upgraduated p53 expression after exposed to Ag-NPs for 48 h when compared
with L-929. It could be concluded that EBF exhibited a more sensitive response to Ag-NPs compared with L-929 cells, indicating
that EBF may be a valid candidate for cytotoxicity screening assays of nanoparticles.
1. Introduction
The unique physicochemical properties of nanomaterials
have allowed their rapid progress and acceptance into
nanobiotechnology and life science. There are reports that
silver nanoparticles (Ag-NPs) have been widely accepted in
catheters [1], wound dressings [2], and the clothing and food
industry [3] due to their eﬃcacy as antimicrobial agents.
Despite this progress, their potential adverse eﬀects on
human health and the environment have not yet been elabo-
rately elucidated, and their biocompatibility remains contro-
versial.
Ag-NPs may translocate to the circulatory system and
distribute throughout the main organs of the body, especially
the kidney, liver, and brain [4], and they can penetrate the
blood-testis and blood-brain barriers [5]. This observation
implies that Ag-NPs could become neurotoxic and genotoxic
[4]. A Previous study has reported that 15 nm Ag-NPs
could lead to drastically reduced mitochondrial function
and cell viability of mouse spermatogonial stem cells at
concentration of 5–10 μg/mL [6]. Hussain et al. [7] reported
that 15 nm Ag-NPs exhibited significant cytotoxicity at 10–
50 μg/mL in the BRL 3A cell line. Other studies have also
reported adverse cellular reactions of Ag-NPs to other cell
types, such as NIH3T3, vascular smoothmuscle cells [8], and
mouse embryonic stem cells [9]. But inconsistency, such as
diﬀerent toxic concentration, indeed exists among the results
of numerous cytotoxicity studies, which may be ascribed
to the varied cell models used in the evaluation of Ag-NPs
cytotoxicity to a certain degree.
Recently, embryonic stem cells (ESCs) have gained great
attention and showed multiple potential in tissue regenera-
tion, drug screening, and biomaterial cytotoxicity test [10,
11]. With the development of methodologies for obtaining
cells derived from human ESCs (hESCs), several advantages
of the diﬀerentiated progenies from hESCs have been
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reported. Unlike immortalized cell lines, which are usually of
cancerous origin, containing chromosomal and genetic aber-
rations that produce immortality, and highly accustomed to
in vitro culture conditions after countless passages, hESCs
have been demonstrated to be genetically and karyotypically
normal, which would make themmore representative of how
a normal cell should behave in vivo. Nowadays, several estab-
lished hESC lines are readily available, from which an almost
limitless supply of diﬀerentiated somatic progenies can be
obtained. Furthermore, diﬀerentiated somatic progenies are
expected to show little inter-batch variability, provided in
vitro culture and diﬀerentiation protocols are well stan-
dardized [12]. Therefore, we proposed the hypothesis that
diﬀerentiated somatic progenies derived from hESCs may be
advantageous in the evaluation of Ag-NPs toxicity and may
be used as a novel option in nanocytotoxicity studies.
This study was planned to study the cytotoxicity of Ag-
NPs (20 nm and 100 nm) to human embryonic stem cell-
derived fibroblasts (EBFs) in comparison with L-929 cell line.
Cell proliferation, cell cycle, apoptosis, p53 expression, and
cellular uptake were examined. Whether EBF could be a valid
candidate as a cell model for cytotoxicity screening of Ag-NPs
or not was analyzed.
2. Materials and Methods
2.1. Materials and Chemicals. Ag-NPs with two diﬀerent
sizes, that is, Ag-NPs-1 (20 nm) and Ag-NPs-2 (100 nm),
were provided by Hongwu Nanomaterial Co. Ltd. (Xuzhou,
China). L-929 cells were obtained from the American Type
Cell Culture Collection (ATCC, Rockville, MD, USA).
Dulbecco’s Modified Eagle’s Medium (DMEM), RPMI
1640, fetal bovine serum (FBS), antibiotic agent (penicillin-
streptomycin, PS), trypsin-EDTA, DMEM/F-12, knockout
serum replacement, nonessential amino acid, and L-
glutamine were purchased from Gibco (Grand Island, NY,
USA). Basic fibroblast growth factor (bFGF) was obtained
from Invitrogen (Carlsbad, CA, USA). β-mercaptoethanol
was provided by Sigma-Aldrich (St. Louis, MO, USA).
Annexin-V-FLUOS staining kit was purchased from Roche
Molecular Biochemicals (Mannheim, Germany). Cell
Counting Kit-8 (CCK-8) was purchased from Dojindo
Laboratories (Tokyo, Japan). All other chemical solvents
were of analytical grade with no further purification.
2.2. Characterization of Ag-NPs. Scanning electron micros-
copy (SEM), transmission electron microscope (TEM), and
energy-dispersive X-ray spectroscopy (EDX) analysis were
used to characterize the size, morphology, distribution, and
chemical purity of the Ag-NPs.
2.3. Cell Culture. The NIH-registered hESC line, H9, was
obtained from the National University of Singapore. H9 cells
were cultured on a layer of mitomycin C-inactivated mouse
embryonic fibroblasts (MEFs) in ESC medium (Table 1)
at 37◦C with 5% CO2 atmosphere and 95% humidity. H9
cells were digested with 1mg/mL collagenase IV, scraped
down from MEF feeder layers, and cultured as embryonic
bodies (EBs) in suspension with EB medium (Table 1) for
5 days. Then, the EBs were transferred to a new flask coated
with 0.1% gelatin and cultured with diﬀerentiation medium
(Table 1). EBs diﬀerentiated spontaneously to fibroblast-like
cells, named EBF cells. EBF and L-929 cells were, respectively,
cultured in DMEM and RPMI 1640. Cells weremaintained at
37◦C in a 5% CO2 atmosphere and 95% humidity. The cells
were subcultivated when they reached 80% confluency.
2.4. In Vitro Assay for Cytotoxic Activity of Ag-NPs
2.4.1. Cell Viability Assay. Cell viability was quantified using
a CCK-8 assay as per manufacturer’s protocol. In brief, cells
were seeded in 96 well plates at a density of 1× 104 cells
(200 μL/well) followed by overnight incubation. The super-
natant was then aspirated from the well, and fresh aliquots of
growth medium (containing Ag-NPs in concentration of 0.5,
5, 50, and 500 μg/mL) after ultrasonic dispersion were added.
After 24, 48, and 72 h, the supernatant was again aspirated,
and cell monolayers were washed with PBS. Subsequently,
water-soluble tetrazolium (WST) reagent (20 μL) was added
in each well, incubated for 4 h, centrifuged, the supernatant
obtained, and absorbance at two wavelengths (415 nm and
630 nm) was recorded using a microplate reader (Bio-Rad
680, Microplate Master, Hercules, CA, USA). The eﬀect of
nanoparticles on cells was expressed as the percentage of cell
viability compared with the controls or relative proliferation
rate (RPR), which is calculated as the following formula:
RPR (%)= (A−AN ) / AN × 100%, where A represents the
absorbance of each diﬀerent concentration group; AN is the
absorbance of negative control group.
2.4.2. Cell Cycle Analysis. Cell cycle analysis was carried out
by propidium iodide (PI) staining followed by flow cytome-
try measurement of the fluorescence. Approximately, 1× 105
cells were placed in cell culture flask. Following treat-
ment with Ag-NPs (50 μg/mL) for 24, 48, and 72 h, the
medium was removed and stored. Cells were washed in
PBS, trypsinized, harvested in the stored medium, and
centrifuged. The pellet was washed, fixed in ice-cold ethanol
(70%), and stored at −20◦C. Before flow cytometry analysis,
cells were washed in PBS and stained with PI in RNase
(50 μg/mL PI and 0.25mg/mL RNase A) and incubated at
37◦C for 1 h, followed by incubation at 4◦C until analysis.
Flow cytometry analysis was performed using BD FACS
Calibur (BD Biosciences) at an excitation wavelength of
488 nm and emission wavelength of 610 nm. Data collected
for 1× 106 cells was analyzed using CellQuest software 6.0
(BD Biosciences).
2.4.3. Annexin-V Staining Apoptosis Analysis. Annexin-V
staining was performed to analyze apoptosis induced by Ag-
NPs. Cells were treated with 50 μg/mL Ag-NPs for 48 h. Cell
preparation and experimental procedures were as for cell
cycle analysis. The staining was performed as per manufac-
turer’s instructions. Data analyses were performed using Cell
Quest software 6.0.
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Table 1: The component of cells culture medium.
Cells culture medium Component
ESC medium DMEM/F-12 supplemented with 20% knockout serum replacement, 4 ng/mL bFGF, 1mmol/L L-glutamine,
1% non essential amino acid, and 0.1mmol/L β-mercaptoethanol
EB medium DMEM/F-12 supplemented with 20% knockout serum replacement, 1mmol/L L-glutamine, 1% non essential
amino acid, and 0.1 mmol/L β-mercaptoethanol
Diﬀerentiation medium DMEM, 1mmol/L L-glutamine and 10% FBS
EBF medium DMEM containing 10 units/mL penicillin, 10 units/mL streptomycin and, 10% FBS












































































































Figure 1: Characterization of Ag-NPs by SEM, EDX and TEM: (a) Ag-NPs-1 SEM with DEX image, (b) size distribution histogram and
TEM image of Ag-NPs-1, (c) Ag-NPs-2 SEM with DEX images, (d) size distribution histogram and TEM image of Ag-NPs-2.
2.5. Cellular Uptake and Quantitative Determination of the
Uptake of Ag-NPs. Ultrathin sections of cells were analyzed
using TEM to reveal the uptake and distribution of NPs.
Briefly, the cells (1.5× 106) were treated with Ag-NPs
(50 μg/mL) for 48 h. At the end of the incubation period,
culture flasks were washed many times with PBS to remove
excess unbound NPs. Cells were trypsinized and fixed in
2.5% glutaraldehyde for 2 h. Fixed cells were washed with
PBS. Postfixation staining was achieved using 1% osmium
tetroxide for 1 h at room temperature. Cells were washed
well, dehydrated in alcohol, and treated with propylene oxide
for 30min, followed by treatment with propylene oxide,
Spurr’s low viscosity resin (1 : 1) for 18 h. Cells were further
treated with pure resin for 24 h and embedded in BEEM cap-
sules containing pure resin. Resin blocks were hardened at
70◦C for 2 days. Ultrathin sections (70 nm) were cut using an
ultramicrotome (Lecia EM UC6). The sections were stained
with 1% lead citrate and 0.5% uranyl acetate and analyzed
under transmission electron microscope examination (H-
7650B, Hitachi, Japan).
Subconfluent cells were incubated at 37◦C in the presence
or absence of 50 μg/mL Ag-NPs for 24 h under cell culture

































































































































Figure 2: Cytotoxicity assay of EBF and L-929 cells after treatment with Ag-NPs (0.5–500 μg/mL) for 24, 48, and 72 h. (a) Ag-NPs-1 24 h, (b)
Ag-NPs-1 48 h, (c) Ag-NPs-1 72 h, (d) Ag-NPs-2 24 h, (e) Ag-NPs-2 48 h, (f) Ag-NPs-2 72 h. ∗Astatistically significant diﬀerence between
EBF and L-929 cells (P < 0.05).
conditions. Subsequently, the cells were washed with PBS,
detached with trypsin and suspended in medium. The
uptake of particles into cells was analyzed using flow cytom-
etry. The side scatter data were analyzed using CELL Quest
6.0 software. Calibration reagents and solutions for flow
cytometry were from Becton Dickinson. Ten thousand cells
were acquired for each measurement.
2.6. Real-Time Quantitative-Polymerase Chain Reaction
(RTq-PCR). To assess DNA damage associated with the Ag-
NPs, the level of p53 expression in cells was detected using
RTq-PCR. The cells were seeded with 1× 105, cells/dish and
cultured with the 50 μg/mL Ag-NPs solution for 48 h. Total
RNA was isolated with TRIZOL Reagent (Invitrogen) and
was reverse transcribed using an iScript cDNA synthesis
kit (Bio-Rad Laboratories). RTq-PCR was performed with
a two-step RTq-PCR kit (Invitrogen) according to the
manufacturer’s instructions. The mRNA expression of p53,
an important signaling molecule in checkpoint responses to
DNA damage [13], was detected after treatment by a 7500
real-time PCR System (Applied Biosystems) with the SYBR










Premix Ex Taq Perfect Real Time kit (Takara Mirus Bio,
Madison, WI). The sequences of the primer pairs are shown
in Table 2.
2.7. Statistical Analysis. All experiments were performed in
duplicate and repeated at least three times. The statistical sig-
nificance of the data was expressed as mean± SD. Statistical
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Figure 4: Expression of p53 in EBF and L-929 following Ag-NPs
exposure for 48 h. ∗Significant diﬀerences in comparison with
control group (P < 0.05). ∗∗Highly significant diﬀerences in com-
parison with control group (P < 0.01).
diﬀerences between groups were evaluated by Student t-test
using the software SPSS 13.0 (SPSS Science). P values of less
than 0.05 were considered to be statistically significant.
3. Results and Discussion
3.1. Characterization of Ag-NPs. Both kinds of Ag-NPs were
observed to be spherical in shape (Figures 1(a) and 1(c))
under SEM, with average size of 20 nm± 12.6 nm (Ag-NPs-1,
Figure 1(b)) and 100± 21.3 nm (Ag-NPs-2, Figure 1(d)), as
measured by software Image J (National Institutes of Health,
USA). EDX results demonstrated that the nanoparticles were
100% pure silver. TEM image showed the even distribution
of Ag-NPs dispersed in water.
3.2. Cytotoxicity of Ag-NPs
3.2.1. Cell Viability of EBF and L-929 Cells. Cell viability was
quantified using a CCK-8 assay. Figure 2 displays the RPR
of EBF and L-929 cells after 24, 48, and 72 h exposure to Ag-
NPs-1 and Ag-NPs-2 at concentration of 0.5–500 μg/mL. The
RPR were decreased in a dose-dependent manner and the
RPR of EBF treated with Ag-NPs of both size were lower than
that of L-929 cells at the same concentration and time point.
50 μg/mL was shown the threshold concentration that signif-
icantly inhibited EBF proliferation, and this concentration
was used in all subsequent experiments including cell cycle
analysis, apoptosis assay, cellular uptake, and p53 expression.
When the NPs concentration reached 500 μg/mL, nearly no
viable cells existed. CCK-8 results also showed apparent
size-dependent cytotoxic eﬀects on cell proliferation. The
RPR of EBF treated with Ag-NPs-1 was lower than that of
Ag-NPs-2 at 5–50 μg/mL, both at 48 and 72 h. However,
the size-dependent cytotoxic eﬀects on L-929 cells occurred
only at 50 μg/mL after 72 h exposure in this study. These
results indicated that EBFmay be more vulnerable to Ag-NPs
treatment when compared with L-929 cell line.
The dose-dependent toxicity pattern of Ag-NPs was
consistent with previous studies on mammalian germline
stem cells [6] and may be due to the impact of endocytosis













Figure 5: Phase-contrast micrographs (magnification 200x) of EBF and L-929 cells before (a) and (b) and after (c) and (d) treatment with
Ag-NPs-1 at 50 μg/mL for 48 h. The insets show the high magnification (magnification 400x).
and metabolism inhibiting normal cellular activity at larger
concentrations of Ag-NPs. The results in our study that
cell proliferation in EBF was more sensitive to Ag-NPs give
evidence for a cell-type-dependent response in biomaterials
cytotoxicity test. Similarly, Cao et al. [14] reported that
mitomycin C decreased EBF viability more obviously than
L-929 cells and considered that EBF were more sensitive than
L-929 cells in cytotoxicity screening tests. Tedja et al. [15]
noticed that the diﬀerent level of biological response should
be primarily attributed to the diﬀerence in the amount of
cellular particle uptake between diﬀerent cell types. Hence,
the cell-type-specific response of cells to Ag-NPs here could
be due to that EBF are genetically and karyotypically normal
and exhibited a stronger capacity to ingest NPs (Figure 7).
Previous studies have also indicated that Ag-NPs have a size-
dependent cytotoxicity, with smaller particles being more
toxic [16, 17]. According to Carlson et al. [18], Ag-15 nm
and Ag-30 nm NPs showed more cytotoxicity than that of
Ag-55 nm. Our study revealed similar findings that the RPR
of EBF and L-929 cells treated with Ag-NPs-1 was lower than
that with Ag-NPs-2. The reason may be that smaller Ag-NPs
have a larger surface area available for interaction and lead to
a stronger eﬀect than larger particles [19].
3.2.2. Cell Cycle Analysis. The influence of NPs on the cell
cycle was analyzed by subjecting the NP-treated cells to
flow cytometry. In control group, major cell populations
were observed in the G1 phase, whereas in Ag-NPs treated
cells, a decrease in the G1 cell population was accompanied
by an increase in the G2/M cell population (Figure 3).
The G2/M population of Ag-NPs treated EBF cells were
significantly increased to almost twice the control values at
24, 48, and 72 h (Figure 3(a)). G2/M arrest of L-929 cells was
observed at 72 h (Figure 3(b)). DNA damage was proposed
to be the main cause of cell cycle arrest [20]. AshaRani
et al. [21] reported oxidative stress in Ag-NPs treated cells
indicating the possibility of DNA damage and chromosomal
aberrations which was considered the prime factors resulting
in cell cycle arrest. The results in this study indicated that EBF
cells may be more vulnerable to Ag-NPs than the L-929 cell
line.
3.2.3. Apoptosis and DNA Damage Induced by Ag-NPs.
Annexin-V staining indicated that the rate of EBF cells
apoptosis was increased from 0.77± 0.08% (control) to
2.88± 0.23% (Ag-NPs-1) and 1.49± 0.33% (Ag-NPs-2) at
50 μg/mL, whereas that of L-929 cells treated with the







































Figure 6: TEM images of ultrathin sections of EBF (a)-(d) and L-929 (e)-(h) cells treated with Ag-NPs after 48 h. Nanoparticles were showed
inside the cytoplasm (c), but they were not in the nucleus (n) of both cell types. Cells showed large endosomes (a) and (e) and lysosomes (b)
and (f) with nanoparticles inside (red arrow). Invagination (c) and (g) and protrusion (d) and (h) of the plasma membrane were observed
































Figure 7: Intracellular occurrence of Ag-NPs agglomerates ana-
lyzed using flow cytometric light scatter. ∗Significant diﬀerences
between EBF and L-929 cells (P < 0.05). #Significant diﬀerences
between Ag-NPs-1 and Ag-NPs-2 groups.
same concentration of Ag-NPs had no significant change
compared with the control (Table 3). This result showed that
the impact of early apoptosis, at the concentration of Ag-
NPs selected in our study, was not apparent, but the value
Table 3: The rate of apoptosis treated with Ag-NPs.
Control Ag-NPs-1 Ag-NPs-2
EBF 0.77± 0.08 2.88± 0.23∗ 1.49± 0.33∗
L-929 0.63± 0.13 0.74± 0.09 0.67± 0.29
∗
P < 0.05 compared with control.
did show that Ag-NPs might cause EBF apoptosis. In the
presence of DNA damage, p53 accumulates and triggers cell
cycle arrest to provide time for the damage to be repaired
[22]. Therefore, p53 expression could be assessed by RTq-
PCR tomonitor the DNA damage indirectly. Data in Figure 4
showed that expression of p53 in EBF cells treated with both
sized Ag-NPs within 48 h increased significantly. Especially
in Ag-NPs-2 treated EBF cells, their p53 expression even
reached almost 14 times of the control group. While the
changes observed in the L-929 cells were not statistically sig-
nificant (Figure 4). Ahamed et al. [9] have also indicated that
Ag-NPs up-regulated p53, Rad51 and phosphorylated-H2AX
expression. This observation supported the hypothesis that
Ag-NPs can cause DNA damage and resulted in G2/M cell
cycle arrest, which may be correlated to long-term eﬀects,
such as mutagenesis or carcinogenesis [23].
3.3. Cellular Uptake and Distribution of Ag-NPs. Under
phase-contrast microscopy, Ag-NPs were observed in the
cytoplasm of both cell types and gathered in the perinucleus.
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Single or clustered NPs were attached to the cell membrane
and were internalized into cells (Figures 5(c) and 5(d)). TEM
images also showed that the NPs were distributed throughout
the cytoplasm, but they were not observed in the nucleus
of both cell types (Figures 6(a) and 6(e)). According to the
TEM images, there were no significant diﬀerences in cellular
uptake between the two cell types. Large endosomes and
lysosomes with Ag-NPs were also observed (Figures 6(a),
6(b), 6(e), and 6(f)). Invagination of plasma membranes
(Figures 6(c) and 6(g)) denoted the endocytosis of nano-
materials. The protrusion of the plasma membrane (Figures
6(d) and 6(h)) for uptake of the nanospheres indicated
the characteristics of endocytosis and macropinocytosis.
These results suggested that Ag-NPs were entering the
cells through pinocytosis rather than diﬀusion. Greulich
et al. [24] have reported that the uptake of PVP-coated
Ag-NPs was significantly inhibited by chlorpromazine and
wortmannin, suggesting endocytosis and macropinocytosis
were the primary uptake mechanisms.
The uptake of nanomaterials depended not only on the
particle size and charge, but also on the cell type [25]. The
quantitative uptake of Ag-NPs was determined by analysis of
the intracellular side scatter signal using flow cytometry. As
Figure 7 demonstrated, EBF had the stronger uptake capacity
of Ag-NPs compared with L-929 cells. The results also
showed that both cell types took up more Ag-NPs-1 particles
than Ag-NPs-2, which might be due to the smaller diameter
and resulted in size-dependent nanotoxicity. The diﬀerences
in uptake capacity between cell lines can be explained by
the diﬀerentiation state of the cells. There was report that
endocytosis was normally downregulated after treatment of
dendritic cells withmaturation stimuli [26]. As diﬀerentiated
progenies from hESCs, EBFs were less mature than L-929
immortalized cells. Hence, it could be reasonable to speculate
that the diﬀerence between uptake capacity of EBFs and L-
929 might be owing to the diﬀering diﬀerentiation state.
The cellular uptake mechanisms, depending on cell type and
particle size, may also be contributed to, or triggered by, the
ability of NPs to penetrate the plasma membrane [27]. The
uptake of the NPs appears to be quite complicated, therefore,
further work is required to elucidate the underling cellular
uptake mechanism elaborately.
4. Conclusion
In this study, the results showed that cytotoxicity of Ag-NPs
was dependent on dose, cell type, and particle size. Ag-NPs
presented higher cytotoxicity to EBF than to L-929. EBF
exhibited an higher G2/M arrest and more upgraded p53
expression after exposed to Ag-NPs for 48 h when compared
with L-929. According to the cellular uptake analysis, the NPs
were found in the cytoplasm and lysosomes, but they were
not observed in the nucleus. EBF demonstrated a stronger
capacity to ingest Ag-NPs. According to the results of this
study, it could be postulated that EBF was more sensitive
to Ag-NPs than L-929. Taking into account of its more
representative of how a normal cell should behave in vivo,
EBF could be considered a promising candidate for cell
model of nanomaterials cytotoxicity screening.
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